Boston Scientific Corporation (BSX)
Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
Boston Scientific (BSX) reached $43.19 at the closing of the latest trading day, reflecting a -1.33% change compared to its last close.
Boston Scientific's Q2 Earnings Coming Up: Buy, Hold or Sell the Stock?
BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts
Boston Scientific (BSX) closed at $44.6 in the latest trading session, marking a -1.2% move from the prior day.
Boston Scientific: The Time Has Come To Catch This Falling Knife
Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's share price has declined by almost 60% to trade at around $45.00 per share. To put my money where my mouth is, I purchased my last shares on June 30th at an average price of $42.83. My overall purchase price now stands at $45.52. As part of its Q1-26 earnings, Boston Scientific announced a significant outlook revision, reducing its organic growth guidance for fiscal 2026 to a range between 6.5% and 8.0%.
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% shift from the previous trading day.
Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity
Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive threats, but fundamentals-based valuation now appears attractive. Growth in key segments like electrophysiology and Watchman has slowed due to increased competition, reimbursement cuts, and less impressive clinical trial data. Management now guides to sub-10% revenue growth (6.5%-8% for the year), but I still expect 7.5% annualized growth over five years and improving margins.
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note
In the most recent trading session, Boston Scientific (BSX) closed at $44.46, indicating a -2.5% shift from the previous trading day.
Boston Scientific (BSX) Gains As Market Dips: What You Should Know
The latest trading day saw Boston Scientific (BSX) settling at $45.6, representing a +2.86% change from its previous close.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note
Boston Scientific (BSX) closed the most recent trading day at $44.95, moving 4.2% from the previous trading session.
